572 – Optimized LNP-Induced Viral Outgrowth Assay to Quantify bNAb Sensitivity in the HIV Latent Reservoir
Background Broadly neutralizing antibodies (bNAbs) are currently being evaluated in clinical trials for HIV treatment and cure as immunomodulatory alternatives to standard antiretroviral therapy (ART). Existing methods are insufficient to accurately predict bNAb sensitivity of HIV-1 in vivo, especially for ART-treated individuals. In pursuit of a rapid, sensitive, and scalable pre-screening method, we report the…